molecular cancer therapeutics

mol cancer ther ISSN 1538-8514 341 views

Indexed In

ncbi ulakbim sci

Publications

1

ULAKBİM MEP: 1.613 Ödeme: 7500 Yılı: 2020

Details

Abbreviated Name: mol cancer ther
ISSN: 1538-8514

Top Clicked Bibliographies from Search

1

Ibrutinib potentiates anti-hepatocarcinogenic efficacy of sorafenib by targeting EGFR in tumor cells and BTK in immune cells in the stroma.

2019 362 clicks